ArticleCancers2021

Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment.

Zoe X Malchiodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.